Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemiaSophie Park, Didier Bouscary, Nicolas Chapuis et al.|Haematologica|2009Cited by 316
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Didier Bouscary, Thiago Trovati Maciel et al.|Blood|2013Cited by 286
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S. Green, Jérôme Tamburini, Nicolas Chapuis et al.|Blood|2010Cited by 196
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemiaJérôme Tamburini, Didier Bouscary, Alexa S. Green et al.|Blood|2009Cited by 185
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemiaLise Willems, Jérôme Tamburini, Nicolas Chapuis et al.|Leukemia|2011Cited by 161